(Q44070538)

29 November 2017

Effect of MK-801 on the antinociceptive effect of [D-Ala(2),N-MePhe(4), Gly-ol(5)]enkephalin in diabetic mice (English)

1 reference

29 November 2017

0 references

Ko Zushida

1

1 reference

PubMed ID

12126969

29 November 2017

Junzo Kamei

series ordinal

2

1 reference

PubMed ID

12126969

29 November 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

European Journal of Pharmacology

29 November 2017

1 reference

29 November 2017

448

1 reference

29 November 2017

1

1 reference

29 November 2017

39-44

1 reference

Intrathecal co-administration of morphine and excitatory amino acid agonists produce differential effects on the tail-flick of intact and spinal rats.

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901905-2

Intrathecal N-methyl-D-aspartate (NMDA) induces paradoxical analgesia in the tail-flick test in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901905-2

The behavioural effects of an N-methylaspartate receptor antagonist following application to the lumbar spinal cord of conscious rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901905-2

Evidence for involvement of N-methylaspartate receptors in 'wind-up' of class 2 neurones in the dorsal horn of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901905-2

Differential effects of excitatory amino acid antagonists on dorsal horn nociceptive neurones in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901905-2

NMDA receptor subunits are modified transcriptionally and post-translationally in the brain of streptozotocin-diabetic rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901905-2

The role of excitatory amino acid transmission within the rostral ventromedial medulla in the antinociceptive actions of systemically administered morphine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901905-2

Activation of brainstem N-methyl-D-aspartate receptors is required for the analgesic actions of morphine given systemically

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901905-2

Intrathecal morphine in mice: a new technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901905-2

The NMDA receptor: central role in pain inhibition in rat periaqueductal gray

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901905-2

Role of spleen or spleen products in the deficiency in morphine-induced analgesia in diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901905-2

Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by μ-opioid agonists, but not by δ- and κ-opioid agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901905-2

The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901905-2

Sex differences in the inhibitory effects of the NMDA antagonist, MK-801, on morphine and stress-induced analgesia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901905-2

A pharmacologic analysis of mechanical hyperalgesia in streptozotocin/diabetic rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901905-2

Possible involvement of spinal protein kinase C in thermal allodynia and hyperalgesia in diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901905-2

Role of intracellular calcium in thermal allodynia and hyperalgesia in diabetic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901905-2

Intrathecal N-methyl-D-aspartate (NMDA) activates both nociceptive and antinociceptive systems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901905-2

Differential antagonism by MK-801 against antinociception induced by opioid receptor agonists administered supraspinally in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901905-2

The differential expression of 16 NMDA and non-NMDA receptor subunits in the rat spinal cord and in periaqueductal gray

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901905-2

Evidence for a central component of post-injury pain hypersensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901905-2

Studies on the spinal interaction of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic mononeuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901905-2

Intracerebroventricular injection of the N-terminal substance P fragment SP(1-7) regulates the expression of the N-methyl-D-aspartate receptor NR1, NR2A and NR2B subunit mRNAs in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901905-2

10.1016/S0014-2999(02)01905-2

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference

PubMed ID

12126969